Home » Topics » Regulatory » Patents

Patents
RSS

Cell adhesion inhibitors claimed by Nippon Shinyaku

Jan. 23, 1997

Toyama discloses antiplatelet agents

Jan. 23, 1997

New endothelin antagonists from Zeneca

Jan. 22, 1997

New agents for treating encephalopathies from Takeda

Jan. 22, 1997

New antimigraine drug candidates from Lilly

Jan. 22, 1997

Yamanouchi reports 5-HT3 agonists for GI indications

Jan. 22, 1997

Histamine H3 receptor antagonists in development at Gliatech

Jan. 22, 1997

GI motility stimulants reported by Janssen

Jan. 22, 1997

New 5-HT1A receptor ligands reported by Bayer

Jan. 21, 1997

New cardiovascular agents from Sigma-Tau

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.